Tao Capital Management LP Denali Therapeutics Inc. Transaction History

Tao Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$16.2 - $23.18 $49,280 - $70,513	3,042 New	3,042 $66,000
Q2 2023 Aug 14, 2023	BUY	$23.37 - $32.96 $85,323 - $120,336	3,651 New	3,651 $108,000
Q4 2021 Feb 11, 2022	SELL	$42.59 - $55.02 $1.66 Million - $2.14 Million	-38,949 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$48.48 - $78.23 $1.89 Million - $3.05 Million	38,949 New	38,949 $1.97 Million
Q2 2021 Aug 16, 2021	SELL	$50.3 - $78.44 $306,125 - $477,385	-6,086 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$53.8 - $81.53 $327,426 - $496,191	6,086 New	6,086 $348,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.12B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Tao Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Tao Capital Management LP with notifications on news.